4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000021
CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $75.64 ($1,134,579)
- CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
PICKERING GRANT · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,000 | $2.03 | $30,450 | 493,888 | D |
| 2024-06-24 | Sale : show line 2 in the form 10b5-1 | −10,341 | $75.39 | $779,577 | 483,547 | D |
| 2024-06-24 | Sale : show line 3 in the form 10b5-1 | −4,471 | $76.17 | $340,565 | 479,076 | D |
| 2024-06-24 | Sale : show line 4 in the form 10b5-1 | −188 | $76.80 | $14,437 | 478,888 | D |
| Open-market sales · 15,000 sh · avg $75.64 · $1,134,579 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-24 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | +15,000 | 197,327 | D |
Loading xslF345X05/wk-form4_1719348224.xml…